Current status of unoprostone for the management of glaucoma and the future of its use in the treatment of retinal disease

Author： Harms Nathan V   Toris Carol B  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.1, 2013-01, pp. : 105-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and future treatment of Lyme disease

By Ravishankar J.   Lutwick L.I.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 2, 2001-02 ,pp. : 241-251

Informa Healthcare

Access to resources Recommend Favorite

The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 3, 2014-09 ,pp. : 169-181

Bentham Science Publishers

Access to resources Recommend Favorite

Leptin and the treatment of obesity: its current status

By Lee D.W.   Leinung M.C.   Rozhavskaya-Arena M.   Grasso P.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 129-139

Elsevier

Access to resources Recommend Favorite

Current Status of Tyrosine Hydroxylase in Management of Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 4, 2012-06 ,pp. : 450-455

Bentham Science Publishers

Access to resources Recommend Favorite

Ocular Carteolol: A Review of its Use in the Management of Glaucoma and Ocular Hypertension

By Henness Sheridan   Tracy Swainston Harrison   Keating Gillian M.  

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 509-528

Adis International

Access to resources Recommend Favorite